603520 logo

Zhejiang Starry Pharmaceutical
603520

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥4.31B
EV
CN¥6.68B
Shares Outstanding
438.41M
Beta
0.68
Industry
Drug Manufacturers - Specialty & Generic

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
1
P/E 2025E
57.88x
P/Revenue 2025E
1.62x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
21.11%
Net Profit Margin 2025E
2.80%
ROE 2025E
2.78%
ROCE 2024
-2.24%

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Zhejiang Starry Pharmaceutical Co.,Ltd.

gainify
603520 logo

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydr...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Shen, Weiyi

Employees

1,754

IPO Date

2016-03-09

Headquarters

Modern Industrial Cluster Area, No. 9 West Fengxi Road, Xianju County, Taizhou, Zhejiang Province, 317306, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.